Literature DB >> 29361471

A turning point in the fight against ovarian cancer?

Giovanni Scambia1, Gabriella Ferrandina2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29361471     DOI： 10.1016/S1470-2045(18)30005-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.

Authors:  Junchen Chen; Yi Li; Heng Cui
Journal:  Arch Gynecol Obstet       Date:  2020-10-03       Impact factor: 2.344

Review 2.  Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas.

Authors:  Michela Camilla Milanesio; Silvia Giordano; Giorgio Valabrega
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.